摘要
Introduction & Background: Sigma-1 receptors (S1R) are chaperone proteins implicated in neuropsychiatric and neurodegenerative disorders. The novel radiotracer [18F]FBFP has showed promise for S1R imaging in non-human-primate (NHP) studies. Enantiopure (R)-[18F]FBFP and (S)-[18F]FBFP were also synthesized and studied in NHPs. In this study we assessed the kinetic and binding properties of (S)-[18F]FBFP in humans.
Methods: Eight subjects underwent PET studies (180 to 240 min long) with (S)-[18F]FBFP. Six subjects also underwent blocking studies with donepezil (10 mg orally, 3.3±0.3 hours before tracer injection). Eighteen primary regions of interest were delineated. Regional time-activity curves (TACs) were generated and analyzed with the one- and two-tissue compartment (1TC and 2TC) models and multilinear analysis 1 (MA1) to determine the most suitable quantification method for regional volume of distribution (VT). The occupancy plots were used to determine S1R blockade by donepezil and non-displaceable volume of distribution (VND).
Results: Brain uptake of (S)-[18F]FBFP peaked at standardized uptake value (SUV) of 10.4±1.6 in frontal cortex at ~48 min and SUV of 2.5±0.5 in white matter (WM) at ~98 min. 2TC K1 values ranged from 0.17±0.04 (WM) to 0.88±0.17 mL/min/cm3 (Frontal cortex). At baseline, 1TC fits were visually good, but not in the blocking scans. However, the 2TC model provided unreliable VT estimates in many cases. Thus, MA1 with a t* value of 40 min was selected for quantification of VT values. Baseline VT values ranged from 50.3±9.3 (WM) to 146.2±21.1 mL/cm3 (Amygdala). Occupancy plots were compatible with a single binding site and S1R occupancy by donepezil was 74%±8%, with (S)-[18F]FBFP VND of 9.2±4.9 mL/cm3. Regional non-displaceable binding potential (BPND) ranged from 4.5±0.7 (WM) to 14.9±3.1 (Amygdala).
Conclusions: (S)-[18F]FBFP appears to be a promising tracer to image S1R in the human brain. Studies using (R)-[18F]FBFP are also underway to compare the two enantiomers.
